1009820-21-6
1009820-21-6
Chemical Structure
Silmitasertib
Synonym(s): CX-4945
- CAS. Nr.: 1009820-21-6
- Formula:C19H12ClN3O2
- Molecular Weight:349.77
IUPAC Name: 5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid
InChIKey: MUOKSQABCJCOPU-UHFFFAOYSA-N
SMILES: O=C(C1=CC=C2C3=C(C(NC4=CC=CC(Cl)=C4)=NC2=C1)C=CN=C3)O
Biological Activity: Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Silmitasertib | 99.81% | Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Silmitasertib (Standard) | ≥98% | Silmitasertib (Standard) is the analytical standard of Silmitasertib. This product is intended for research and analytical applications. Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
